文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

急诊科疑似脓毒症患者有核红细胞对预后的价值:单中心前瞻性队列研究

Prognostic Value of Nucleated RBCs for Patients With Suspected Sepsis in the Emergency Department: A Single-Center Prospective Cohort Study.
PubMed 文献 · Crit Care Explor · 2021-07-16
一句话结论急诊疑似脓毒症患者入院首次血样有核红细胞≥0.01×10^9/L者30天死亡率26%,显著高于低于检测限者的12%。

入院首次血样有核红细胞≥0.01×10^9/L者262例,30天死亡率26%;低于检测限者969例,死亡率12%(p<0.0001)。有核红细胞评分每增加1分,30天死亡风险独立增加(OR 1.33,95%CI 1.13-1.56),最高分组死亡率达62%。有核红细胞可为SOFA评分等提供额外预后信息。

要点

  • 急诊疑似脓毒症患者入院首次血有核红细胞≥0.01×10^9/L者30天死亡率26%,低于检测限者12%(p<0.0001)。
  • 有核红细胞评分每增加1分,30天死亡OR为1.33(95%CI 1.13-1.56),独立于SOFA评分(OR 1.32)和Charlson共病指数(OR 1.17)。
  • 有核红细胞最高分组30天死亡率达62%,但评分从2分到3分死亡率升高不显著。
  • 有核红细胞可能为SOFA评分和常用实验室检查提供额外预后信息。

适用人群与场景

  • (本栏提炼含原文里核对不到的数值,已删除,请以原文为准)

诊断标准与关键阈值

  • 有核红细胞检测限为0.01×10^9/L,等于或高于检测限者归为有核红细胞升高组。
  • 有核红细胞计数按水平分为五组,称为「Nucleated RBC score」(有核红细胞评分)。
  • 同时评估Sequential Organ Failure Assessment(SOFA)评分、Quick Sequential Organ Failure Assessment、Charlson Comorbidity Index及常用实验室检查。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 急诊疑似脓毒症患者入院首次血有核红细胞≥0.01×10^9/L提示30天死亡风险显著升高(26% vs 12%),最高有核红细胞评分组死亡率达62%。

研究设计与关键结果

  • 有核红细胞≥0.01×10^9/L者262例,30天死亡率26%;低于检测限者969例,死亡率12%(p<0.0001)。
  • 有核红细胞评分每增加1分,30天死亡OR 1.33(95%CI 1.13-1.56);SOFA评分OR 1.32(95%CI 1.29-1.56);Charlson共病指数OR 1.17(95%CI 1.09-1.25)。
  • 有核红细胞评分每增加1分死亡率显著升高,但评分2分到3分之间例外;最高分组死亡率62%。

证据类型、等级与局限

  • 证据类型:单中心前瞻性队列研究(基于质量登记的前瞻性队列)。
  • 局限:单中心研究;原文未提及其他局限。

对床旁实践的改变

  • 急诊接诊疑似脓毒症患者时,入院首次血样可关注有核红细胞计数,≥0.01×10^9/L提示30天死亡风险升高,可辅助SOFA评分等现有工具进行风险分层。
  • 多数疑似脓毒症患者有核红细胞低于检测限,不能因有核红细胞不高而降低对病情的警惕。
  • 原文未提及基于有核红细胞调整治疗决策,不应据此改变抗生素或复苏方案。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Increase of nucleated RBCs in peripheral blood has been shown to be predictive of mortality in ICU patients. The aim of this study was to explore the prognostic value of nucleated RBCs in the first blood sample taken at admission to the emergency department from patients with suspected sepsis.

DESIGN: Single-center prospective cohort study.

SETTING: Emergency department.

PATIENTS: One-thousand two-hundred thirty-one consecutive adult patients with suspected sepsis were included in a prospective quality register-based cohort study. Inclusion criteria were as follows: patients received in rapid response team with blood cultures taken and immediate antibiotics given in the emergency department.

INTERVENTION: Not applicable.

MEASUREMENT AND MAIN RESULTS: Nucleated RBCs, Sequential Organ Failure Assessment score, Quick Sequential Organ Failure Assessment, Charlson Comorbidity Index, and commonly used laboratory tests measured in the emergency department were compared with 30-day mortality. Nvaucleated RBC counts were divided into five groups, called "Nucleated RBC score," according to nucleated RBC count levels and analyzed with logistic regression together with the Sequential Organ Failure Assessment score and Charlson Comorbidity Index. Of the 262 patients with nucleated RBCs equal to or higher than the detection limit (0.01 × 109/L), 26% died within 30 days, compared with 12% of the 969 patients with nucleated RBCs below the detection limit (p < 0.0001). Mortality was significantly higher for each increase in Nucleated RBC score, except from score 2 to 3, and was 62% in the highest group. In multivariate logistic regression, odds ratios for 30-day mortality were as follows: Nucleated RBC score: 1.33 (95% CI, 1.13-1.56), Sequential Organ Failure Assessment score: 1.32 (1.29-1.56), and Charlson Comorbidity Index: 1.17 (1.09-1.25).

CONCLUSIONS: Most patients with suspected sepsis in emergency department had undetectable nucleated RBCs at admission to the emergency department. However, increased nucleated RBCs significantly predicted 30-day mortality. Nucleated RBCs may provide additional prognostic information to Sequential Organ Failure Assessment score and other laboratory tests.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Amundsen EK, Binde C, Christensen EE, et al. Prognostic Value of Nucleated RBCs for Patients With Suspected Sepsis in the Emergency Department: A Single-Center Prospective Cohort Study. Crit Care Explor. 2021. PMID: 34291222. doi:10.1097/CCE.0000000000000490

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。